Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK

BACKGROUND: Chronic migraine affects 2% of the population. It results in substantial disability and reduced quality of life. Medications used for prophylaxis in episodic migraine may also work in chronic migraine. The efficacy and safety of OnabotulinumtoxinA (BOTOX) in adults with chronic migraine...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalil, Modar, Zafar, Hassan W, Quarshie, Victoria, Ahmed, Fayyaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166400/
https://www.ncbi.nlm.nih.gov/pubmed/25178393
http://dx.doi.org/10.1186/1129-2377-15-54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166400/
https://www.ncbi.nlm.nih.gov/pubmed/25178393
http://dx.doi.org/10.1186/1129-2377-15-54

Ejemplares similares